Kenneth Dorshkind, Ph.D., was appointed as Interm Director of UCLA’s Jonsson Comprehensive Cancer Center on October 1, 2015. Dorshkind serves as professor and vice chair for research for the Department of Pathology and Laboratory Medicine at the UCLA School of Medicine. He is also academic associate director of the Broad Stem Cell Research Center and director of the Cellular and Molecular Pathology Graduate Program.
Dorshkind earned his B.S. in Biology and M.S. in Anatomy at the University of California, Davis, and received a Ph.D. in Biological Structure from the University of Washington, Seattle. He was a postdoctoral fellow at the Ontario Cancer Institute in Ontario, Canada, where he worked on hematopoiesis. Dorshkind has served as a section editor of the Journal of Immunology, a member of the Leukemia and Lymphoma Society of America Career Development Review Subcommittee, and a frequent reviewer for the National Institutes of Health. In 1999, he was named associate director of the Hematopoietic Malignancies Program Area at the UCLA Jonsson Comprehensive Cancer Center and was promoted to director in 2001, a position he served in for ten years.
The current research focus of Dorshkind’s laboratory is on lymphocyte development from hematopoietic stem cells and how that process is regulated by microenvironmental and systemic factors. His team has developed and used a variety of in vitro and in vivo systems to test the developmental potential of various hematopoietic progenitor cell populations. Dorshkind hopes that learning more about early lymphocyte development will provide a basis for understanding the development of certain blood cancers and reveal how age-related declines in lymphocyte production impact the immune system.
Last updated: 10/1/2015 1:27:40 PM